# Dyne Therapeutics, Inc.: Form 8-K, filed Jul 22, 2026

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 17:19 ET
- Period: 2026-07-21
- Accession: 0001193125-26-312571
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000119312526312571/d112911d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000119312526312571/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000119312526312571/d112911d8k.htm

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-312571. Last ingested by Listed: Nov 14, 2026, 19:07 ET. No prices; not investment advice.
